✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Indoco Remedies Ltd.

INDOCO

Market Cap
₹2,629 Cr.
P/E
0.00

Indoco Remedies Ltd.

  • Indoco Remedies
  • Panacea Biotec
  • Novartis
  • TJI Pharma - Small Cap
FAQs on Indoco Remedies Ltd. Shareprice

Indoco Remedies has given lower returns compared to its competitors.
Indoco Remedies has grown at ~5.28% over the last 7yrs while peers have grown at a median rate of 12.34%

Indoco Remedies is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Indoco Remedies is 0.0, while 3 year average PE is 28.57.
Also latest EV/EBITDA of Indoco Remedies is 48.6 while 3yr average is 15.71.

View FAQ's On Business
Growth Table
  • Indoco Remedies Ltd.
  • Panacea Biotec
  • Novartis
Balance Sheet
  • Indoco Remedies Ltd.
  • Panacea Biotec
  • Novartis
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Indoco Remedies Ltd.
  • Panacea Biotec
  • Novartis
Cash Flow
  • Indoco Remedies Ltd.
  • Panacea Biotec
  • Novartis
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Indoco Remedies Ltd.
  • Panacea Biotec
  • Novartis
Quarterly Results
  • Indoco Remedies Ltd.
  • Panacea Biotec
  • Novartis
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Indoco Remedies Ltd. Financials

Balance sheet of Indoco Remedies is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Indoco Remedies is increasing.
Latest debt of Indoco Remedies is ₹714 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹607 Crs.

No, profit is decreasing.
The profit of Indoco Remedies is -₹116.1 Crs for TTM, -₹8.73 Crs for Mar 2025 and ₹117 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Indoco Remedies latest dividend payout ratio is 11.85% and 3yr average dividend payout ratio is 13.26%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech